Annual report pursuant to Section 13 and 15(d)

5. COMMON STOCK TRANSACTIONS (Details Narrative)

v3.20.2
5. COMMON STOCK TRANSACTIONS (Details Narrative) - USD ($)
12 Months Ended
Apr. 30, 2020
Apr. 30, 2019
Apr. 30, 2018
Shelf Offering [Member]      
Stock issued new, shares 333,300,000 161,700,000  
Proceeds from sale of equity $ 2,100,000 $ 2,300,000  
Common Stock [Member] | Director Letter Agreement [Member] | Four Nonemployee Members [Member]      
Stock issued for compensation, shares 2,000,000    
Stock based compensation expense $ 19,212 101,288  
Unvested shares 0    
Common Stock [Member] | Director Letter Agreement [Member] | Four Nonemployee Member [Member]      
Stock issued for compensation, shares 2,000,000    
Stock based compensation expense $ 65,339    
Unvested shares 0    
Common Stock [Member] | Consulting Agreements [Member] | Three Consultants [Member]      
Stock issued for compensation, shares     4,200,000
Stock based compensation expense $ 0 $ 73,800  
Unvested shares 0 0  
Common Stock [Member] | Consulting Agreements [Member] | Five Consultants [Member]      
Stock issued for compensation, shares 3,200,000    
Stock based compensation expense $ 108,575 $ 17,350  
Unvested shares 200,000    
Common Stock [Member] | 2018 Compensation Agreement [Member] | Officers [Member]      
Stock issued for compensation, shares     6,600,000
Stock based compensation expense $ 0 $ 245,520  
Unvested shares 0 0  
Common Stock [Member] | 2019 Compensation Agreement [Member] | Officers [Member]      
Stock issued for compensation, shares   6,600,000  
Stock based compensation expense $ 278,891 $ 47,809  
Unvested shares 0 4,400,000  
Common Stock [Member] | 2019 Compensation Agreement [Member] | Four Consultants [Member]      
Stock issued for compensation, shares   4,450,000  
Stock based compensation expense $ 24,726 $ 230,829  
Unvested shares 0 408,333  
Common Stock [Member] | Medical And Scientific Advisory Board [Member] | A Consultant [Member]      
Stock issued for compensation, shares 2,500,000    
Stock based compensation expense $ 22,584 $ 107,749  
Unvested shares 0    
Common Stock [Member] | 2020 Compensation Agreement [Member] | Officers [Member]      
Stock issued for compensation, shares 6,600,000    
Stock based compensation expense $ 89,759    
Unvested shares 4,400,000    
Common Stock [Member] | Four Directors [Member] | Director Letter Agreement [Member]      
Stock issued for compensation, shares     1,750,000
Stock based compensation expense $ 0 $ 24,165  
Restricted Stock [Member] | Stock Subscription Agreements [Member]      
Stock issued new, shares 103,000,000    
Proceeds from sale of equity $ 515,000